Skip to main content
SpringerLink
Log in

Clinical and retrospective evaluation of eviprostat: A non-hormonal and non-neuropharmacological agent for benign prostatic hyperplasia

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Eviprostat has been used as a non-hormonal and non-neuropharmacological treatment for benign prostatic hyperplasia (BPH) in Japan. We evaluated the clinical efficacy of Eviprostat in patients with symptomatic BPH and the anti-inflammatory effect of this drug was investigated by retrospective evaluation of TUR specimens. Clinically, Eviprostat subjectively relieved obstructive symptoms of BPH. Objective improvements were also demonstrated by ultrasonographic evaluation of prostatic volume and urinary flow rates. Histologically, preoperative administration of Eviprostat improved the degree of prostatic inflammation. This drug probably can have a place in the treatment of patients with mild or moderate symptoms of outflow obstruction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Caine, M., Pfau, A., Perlberg, S.: The use of alpha-adrenergic blockers in benign prostatic obstruction.Br. J. Urol., 48, 255 (1976).

    CAS  PubMed  Google Scholar 

  2. Lepor, H.: Role of alpha-adrenergic blockers in the treatment of benign prostatic hyperplasia.The Prostate, 3, 75 (1990).

    Article  CAS  Google Scholar 

  3. Lepor, H., Henry, D., Laddu, A.: The efficacy and safety of terazosin for the treatment of symptomatic BPH.The Prostate, 18, 345 (1991).

    Article  CAS  PubMed  Google Scholar 

  4. Buck, A. C., Cox, R., Rees, R. W. M., Ebeling, L., John, A.: Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, Cernilton: A double-blind, placebo-controlled study.Br. J. Urol., 66, 398 (1990).

    Article  CAS  PubMed  Google Scholar 

  5. Felder, V. H., Schenk, T.: Die fruhzeitige Erkennung der Prostatahypertrophie und deren konservative Behandlung.Der Landarzt, 33, 290 (1957).

    Google Scholar 

  6. Ookita, K., Shiraga, T., Matsumura, Y.: Clinical report on the use of Eviprostat in the treatment of prostatic hypertrophy.Acta Urol. Jap., 12, 511 (1966).

    CAS  PubMed  Google Scholar 

  7. Odunjo, E. O., Elebute, E. A.: Chronic prostatitis in benign prostatic hyperplasia.Br. J. Urol., 43, 333 (1971).

    Article  CAS  PubMed  Google Scholar 

  8. Kohnen, P. W., Drach, G. W.: Patterns of inflammation in prostatic hyperplasia: A histologic and bacteriologic study.J. Urol., 121, 755 (1979).

    CAS  PubMed  Google Scholar 

  9. Roehrborn, C. G., Chinn, H. K. W., Fulgham, P. F., Simpkins, K. L., Peters, P. C.: The role of transabdominal ultrasound in the preoperative evaluation of patients with benign prostatic hypertrophy.J. Urol., 135, 1190 (1986).

    CAS  PubMed  Google Scholar 

  10. Boyarsky, S., Jones, G., Paulson, D. F., Prout, G. R.: A new look at bladder neck obstruction by the Food and Drug Administration Regulators: Guidelines for investigation of benign prostatic hypertrophy.Trans. Am. Association Genito-Urinary Surg., 68, 29 (1977).

    Google Scholar 

  11. Attah, E. B., Path, M. R. C.: Nonspecific inflammatory lesions of the prostate.Int. Surg., 60, 158 (1975).

    Google Scholar 

  12. Lands, R. R., French, T. N.: Bacterial prostatitis: Incidence in the obstructive prostate.J. Urol., 110, 427 (1973).

    Google Scholar 

  13. de la Rosette, J. J. M. C. H., Debruyne, F. M. J.: Nonbacterial prostatitis: A comprehensive review.Urol. Int., 46, 121 (1991).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Yamagata University, School of Medicine, Yamagata, Japan

    M. Ishigooka, T. Hashimoto, S. Hayami, M. Tomaru & T. Nakada

  2. Department of Urology, Sakata City Hospital, Sakata, Japan

    K. Mitobe

Authors
  1. M. Ishigooka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Hashimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Hayami
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Tomaru
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Nakada
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. Mitobe
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ishigooka, M., Hashimoto, T., Hayami, S. et al. Clinical and retrospective evaluation of eviprostat: A non-hormonal and non-neuropharmacological agent for benign prostatic hyperplasia. International Urology and Nephrology 27, 61–66 (1995). https://doi.org/10.1007/BF02575222

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02575222

Keywords

Search

Navigation